+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Muscle Weakness Drug"

From
Partial Paralysis and Muscle Weakness - Pipeline Insight, 2024 - Product Thumbnail Image

Partial Paralysis and Muscle Weakness - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Muscle Weakness Drug market is a subset of Central Nervous System Drugs, which are used to treat a variety of neurological conditions. These drugs are used to treat muscle weakness, which can be caused by a variety of conditions, including multiple sclerosis, muscular dystrophy, and spinal cord injuries. Muscle weakness drugs can also be used to treat conditions such as myasthenia gravis, which is an autoimmune disorder that affects the neuromuscular junction. These drugs work by increasing the strength of the muscles, allowing them to function more effectively. The Muscle Weakness Drug market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Other companies in the market include AbbVie, Sanofi, and Teva Pharmaceuticals. Show Less Read more